Noninvasive Cardiac Output Monitoring in Pulmonary Hypertension
| Status: | Active, not recruiting |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), High Blood Pressure (Hypertension) |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/6/2019 |
| Start Date: | November 2016 |
Comparison of noninvasive cardiac output monitoring device with Fick and thermodilution
methods during right heart catheterization in patients with pulmonary hypertension.
methods during right heart catheterization in patients with pulmonary hypertension.
Inclusion criteria:
- Age > 18 years
- Diagnosis of Group 1 or Group 4 PAH based on PAPm > 25 mmHg, PAWP <15 mmHg, PVR >3 WU
and consistent clinical history. Note: for logistical reasons, patients at high
suspicion for Group 1 or Group 4 PAH will sign informed consent to have the NICOM
device applied during right heart catheterization before the procedure; if it is found
that the patient does not meet the definition of Group 1 or Group 4 PAH during right
heart catheterization, he/she will be excluded.
- Willingness and ability to comply with study procedures.
- No known hypersensitivity to the components of NICOM electrodes
Exclusion criteria:
- Unwillingness to sign informed consent or inability or unwillingness to comply with
study procedures
- Evidence of postcapillary pulmonary hypertension on right heart catheterization
We found this trial at
1
site
Click here to add this to my saved trials
